AMZN vs MRSN · P/E 31, rev $716.92B vs rev $40.5M
Amazon.com Inc (AMZN) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
AMZN currently screens at market cap $2.55T and trailing P/E 30.6. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the AMZN and MRSN stock pages for the full models.
Not investment advice.